Tag: nih_research_matters
-
Immune System May Attack Nervous System in Some Long COVID Patients
New research suggests the immune system may attack the nervous system, contributing to neurological symptoms in some Long COVID patients. Other studies explore video games for depression screening and an AI tool to speed antibiotic development.
HealthScience & TechnologyMedical ScienceArtificial IntelligenceComputers and InternetSocial IssuesEducation Long COVIDImmune SystemNeurological DisordersMedical ResearchDepressionAntibioticsNIH RESEARCH MATTERS
-
New Tools Advance Understanding of Environmental Exposures and Health
Scientists are now using advanced tools to measure the exposome, the sum of all environmental exposures, to understand its vast influence on health. This research aims to improve prevention and treatment strategies by comprehensively assessing both positive and negative environmental…
HealthScience & TechnologyMedical ScienceEnvironmentSocial Issues ExposomeEnvironmental ExposuresResearchPreventionTreatment StrategiesNational Institutes of HealthNIH RESEARCH MATTERS
-
NIH Research Highlights Advances in TB Diagnosis, Cancer Treatment, and Neurodegenerative Disease
Recent NIH research reveals a rapid tuberculosis diagnostic, a blood test predicting tumor response, and short RNA molecules showing promise against neuron death in ALS and dementia.
HealthScience & TechnologyMedical ScienceEducationSocial Issues TuberculosisCancer TreatmentALSDementiaDiagnostic TestMedical ResearchNIH Research Matters
-
NIH Research Highlights Advances in Blood Pressure, Toxic Metal Impact, and Liver Tissue Growth
New research from NIH Research Matters reveals improved blood pressure control through team-based care, the long-term impact of early toxic metal exposure on brain health, and advancements in growing implanted liver tissue.
HealthScience & TechnologyMedical ScienceEnvironmentSocial IssuesEducation Blood Pressure ControlToxic MetalsLiver TissueHealth CoachingBrain HealthRegenerative MedicineNIH Research Matters
-
GLP-1 Therapy Reduces Heavy Drinking in Patients with Alcohol Use Disorder and Obesity
People with alcohol use disorder and obesity showed reduced heavy drinking when treated with a GLP-1 drug combined with cognitive behavioral therapy, potentially offering a new treatment approach for both conditions.
HealthScience & TechnologyMedical ScienceSocial Issues GLP-1Alcohol Use DisorderObesityCognitive Behavioral TherapyAddiction TreatmentMedical ResearchPublic HealthNIH RESEARCH MATTERS